AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

Fluoxetine Hydrochloride Equivalent To Fluoxetine

15 registrations across 1 African market— 11 active

Markets with Fluoxetine Hydrochloride Equivalent To Fluoxetine

Recent registrations

Brand / ProductMarketHolderStatusExpires
DEFITON 20🇿🇦South AfricaBiotech Laboratories (Pty) LtdactiveMar 2029
NUZAK ORAL SOLUTION🇿🇦South AfricaCipla Medpro (Pty) LtdsuspendedJul 2025
FLUOXETINE ACTOR 20🇿🇦South AfricaCipla Medpro (Pty) LtdsuspendedJul 2025
PROZAC 20🇿🇦South AfricaEli Lilly (S.A.) (Pty) LtdsuspendedApr 2025
REZAK🇿🇦South AfricaDr ReddyÆs Laboratories (Pty) LtdsuspendedNov 2014
PROLAX CAPSULES🇿🇦South AfricaDezzo Trading 392 (Pty) LtdactiveJan 1900
MODIPRAN 20 TABLETS🇿🇦South AfricaiPharma (Pty) LtdactiveJan 1900
DEPROZAN🇿🇦South AfricaElttab Pharmaceuticals CCactiveJan 1900
LORIEN TABLETS🇿🇦South AfricaPharmacare Limited û WoodmeadactiveJan 1900
NUZAK🇿🇦South AfricaCipla Medpro (Pty) LtdactiveJan 1900
FLUOXETINE 20 UNIMED🇿🇦South AfricaUnimed Healthcare (Pty) LtdactiveJan 1900
SERONIL 20 mg🇿🇦South AfricaAlliance Pharma (Pty) LtdactiveJan 1900
MODIPRAN 20 CAPSULES🇿🇦South AfricaiPharma (Pty) LtdactiveJan 1900
MODIPRAN 40 TABLETS🇿🇦South AfricaiPharma (Pty) LtdactiveJan 1900
ZYDUS-FLUOXETINE 20 mg🇿🇦South AfricaZydus Healthcare (Pty) LtdactiveJan 1900

Fluoxetine Hydrochloride Equivalent To Fluoxetine in Africa — Regulatory Overview

Fluoxetine Hydrochloride Equivalent To Fluoxetine is registered across 1 African markets with 15 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including South Africa. AfricaRegulatory refreshes this data daily from official government sources.

Of the 15 registrations, 11 (73%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.